p-aminohippuric acid has been researched along with Diabetes Mellitus, Type 2 in 7 studies
p-Aminohippuric Acid: The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity.
p-aminohippurate : A hippurate that is the conjugate base of p-aminohippuric acid, arising from deprotonation of the carboxy group.
p-aminohippuric acid : An N-acylglycine that is the 4-amino derivative of hippuric acid; used as a diagnostic agent in the measurement of renal plasma flow.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine whether glomerular hemodynamic parameters in humans are associated with glycemic control indices, by simultaneously measuring clearance of inulin (Cin) and para-aminohippuric acid (CPHA)." | 1.40 | Significant association of poor glycemic control with increased resistance in efferent arterioles--study of inulin and para-aminohippuric acid clearance in humans. ( Emoto, M; Fukumoto, S; Ichii, M; Inaba, M; Ishimura, E; Mori, K; Nakatani, S; Ohno, Y; Tsuda, A, 2014) |
| "GFR of the subjects with type 2 diabetes was next examined." | 1.28 | [Measurement of renal plasma flow and glomerular filtration rates in diabetic subjects]. ( Ebata, K; Haneda, M; Kikkawa, R; Shigeta, Y; Sugimoto, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ontawong, A | 1 |
| Saowakon, N | 1 |
| Vivithanaporn, P | 1 |
| Pongchaidecha, A | 1 |
| Lailerd, N | 1 |
| Amornlerdpison, D | 1 |
| Lungkaphin, A | 1 |
| Srimaroeng, C | 1 |
| Tsuda, A | 1 |
| Ishimura, E | 1 |
| Ohno, Y | 1 |
| Ichii, M | 1 |
| Nakatani, S | 1 |
| Mori, K | 1 |
| Fukumoto, S | 1 |
| Emoto, M | 1 |
| Inaba, M | 1 |
| Ritt, M | 1 |
| Ott, C | 1 |
| Raff, U | 1 |
| Schneider, MP | 1 |
| Schuster, I | 1 |
| Hilgers, KF | 1 |
| Schlaich, MP | 1 |
| Schmieder, RE | 1 |
| Pruijm, M | 1 |
| Wuerzner, G | 1 |
| Maillard, M | 1 |
| Bovet, P | 1 |
| Renaud, C | 1 |
| Bochud, M | 1 |
| Burnier, M | 1 |
| Baylis, C | 1 |
| Atzpodien, EA | 1 |
| Freshour, G | 1 |
| Engels, K | 1 |
| Stankovic, AR | 1 |
| Fisher, ND | 1 |
| Hollenberg, NK | 1 |
| Haneda, M | 1 |
| Kikkawa, R | 1 |
| Ebata, K | 1 |
| Sugimoto, T | 1 |
| Shigeta, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes[NCT01835678] | Phase 3 | 65 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Prospective Study on Endothelial Function in Subjects With Type 2 Diabetes Mellitus[NCT00905528] | 69 participants (Anticipated) | Observational | 2002-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for p-aminohippuric acid and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Antioxidant and renoprotective effects of Spirogyra neglecta (Hassall) Kützing extract in experimental type 2 diabetic rats.
Topics: Animals; Antioxidants; Biological Transport; Diabetes Mellitus, Experimental; Diabetes Mellitus, Typ | 2013 |
Significant association of poor glycemic control with increased resistance in efferent arterioles--study of inulin and para-aminohippuric acid clearance in humans.
Topics: Adult; Aged; Arterioles; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; F | 2014 |
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood | 2009 |
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood | 2009 |
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood | 2009 |
Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood | 2009 |
Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region.
Topics: Absorption; Adult; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephr | 2010 |
Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Weight; Diabetes Complication | 2003 |
Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; | 2006 |
[Measurement of renal plasma flow and glomerular filtration rates in diabetic subjects].
Topics: Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Humans; Inulin; p-Aminohippuric Acid; Renal C | 1992 |